Integra Lifesciences Holdings (IART) Enterprise Value (2009 - 2026)
Integra Lifesciences Holdings (IART) reported Enterprise Value of -$265.5 million for Q1 2026, up 2.86% on a YoY basis from -$258.1 million in Q1 2025, and down 0.66% sequentially from -$263.7 million in Q4 2025.
Integra Lifesciences Holdings (IART) Enterprise Value (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings (IART) has 18 years of Enterprise Value data on file, last reported at -$265.5 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 2.86% year-over-year to -$265.5 million; the trailing twelve-month figure through Mar 2026 stood at -$265.5 million (up 2.86% YoY), and the FY2025 full-year result was -$263.7 million, up 3.59% from the prior year.
- Enterprise Value declined to -$265.5 million in Q1 2026, from -$263.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$253.6 million in Q2 2025 to a low of -$663.1 million in Q1 2024.
- A 5-year average of -$344.6 million and a median of -$296.9 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 115.74% in 2024 and soared 58.78% in 2025, its largest moves.
- Tracing IART's Enterprise Value over 5 years: stood at -$456.7 million in 2022, then surged by 32.31% to -$309.1 million in 2023, then gained by 11.49% to -$273.6 million in 2024, then increased by 3.59% to -$263.7 million in 2025, then decreased by 0.66% to -$265.5 million in 2026.
- Business Quant data shows IART's Enterprise Value at -$265.5 million in Q1 2026, -$263.7 million in Q4 2025, and -$267.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.07 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | -577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -3.09 Bn |
| 10 | Integra Lifesciences Holdings | 1.50 Bn | 1.23 Bn | 216.98 Mn | -265.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -265.49 Mn |
| Dec 31, 2025 | -263.74 Mn |
| Sep 30, 2025 | -267.90 Mn |
| Jun 30, 2025 | -253.59 Mn |
| Mar 31, 2025 | -273.30 Mn |
| Dec 31, 2024 | -273.58 Mn |
| Sep 30, 2024 | -277.56 Mn |
| Jun 30, 2024 | -296.94 Mn |
| Mar 31, 2024 | -663.10 Mn |
| Dec 31, 2023 | -309.10 Mn |
| Sep 30, 2023 | -273.73 Mn |
| Jun 30, 2023 | -309.19 Mn |
| Mar 31, 2023 | -307.37 Mn |
| Dec 31, 2022 | -456.66 Mn |
| Sep 30, 2022 | -511.94 Mn |
| Jun 30, 2022 | -447.15 Mn |
| Mar 31, 2022 | -407.09 Mn |
| Dec 31, 2021 | -513.45 Mn |
| Sep 30, 2021 | -470.23 Mn |
| Jun 30, 2021 | -397.41 Mn |